[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Peripheral Arterial Disease (PAD) Therapeutics Market Professional Survey Report 2017

January 2018 | 116 pages | ID: G85754F5DD5EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Peripheral Arterial Disease (PAD) Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • AstraZeneca Plc. (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bristol-Myers Squibb Company (US)
  • Merck & Co., Inc. (US)
  • Proteon Therapeutics, Inc. (US)
  • Sanofi S.A. (France)
  • Symic Bio, Inc. (US)
  • TheraVasc Inc. (US)
  • AnGes MG, Inc. (Japan)
  • Athersys, Inc. (US)
  • Betagenon AB (Sweden)
  • miRagen Therapeutics, Inc. (US)
  • Multi Gene Vascular Systems Ltd (Israel)
  • ViroMed Co. Ltd. (Korea)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Anti-Platelet Drugs
  • Dual Antiplatelet Therapy Drugs
  • Others
By Application, the market can be split into
  • Hospitals
  • Clinics
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Peripheral Arterial Disease (PAD) Therapeutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS

1.1 Definition and Specifications of Peripheral Arterial Disease (PAD) Therapeutics
  1.1.1 Definition of Peripheral Arterial Disease (PAD) Therapeutics
  1.1.2 Specifications of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Classification of Peripheral Arterial Disease (PAD) Therapeutics
  1.2.1 Anti-Platelet Drugs
  1.2.2 Dual Antiplatelet Therapy Drugs
  1.2.3 Others
1.3 Applications of Peripheral Arterial Disease (PAD) Therapeutics
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peripheral Arterial Disease (PAD) Therapeutics
2.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics
2.4 Industry Chain Structure of Peripheral Arterial Disease (PAD) Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016

4 GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Peripheral Arterial Disease (PAD) Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Sales Price
  4.4.2 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis (Company Segment)

5 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.1.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.1.2 North America 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.1.4 North America 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis
5.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.2.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.2.2 China 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.2.4 China 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis
5.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.3.2 Europe 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis
5.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.4.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis
5.5 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.5.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.5.2 Japan 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.5.4 Japan 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis
5.6 India Peripheral Arterial Disease (PAD) Therapeutics Market Analysis
  5.6.1 India Peripheral Arterial Disease (PAD) Therapeutics Market Overview
  5.6.2 India 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price Analysis
  5.6.4 India 2016 Peripheral Arterial Disease (PAD) Therapeutics Market Share Analysis

6 GLOBAL 2012-2017E PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales by Type
6.2 Different Types of Peripheral Arterial Disease (PAD) Therapeutics Product Interview Price Analysis
6.3 Different Types of Peripheral Arterial Disease (PAD) Therapeutics Product Driving Factors Analysis
  6.3.1 Anti-Platelet Drugs of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis
  6.3.2 Dual Antiplatelet Therapy Drugs of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis
  6.3.3 Others of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Consumption by Application
7.2 Different Application of Peripheral Arterial Disease (PAD) Therapeutics Product Interview Price Analysis
7.3 Different Application of Peripheral Arterial Disease (PAD) Therapeutics Product Driving Factors Analysis
  7.3.1 Hospitals of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis
  7.3.2 Clinics of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis
  7.3.3 Others of Peripheral Arterial Disease (PAD) Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS

8.1 AstraZeneca Plc. (UK)
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca Plc. (UK) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca Plc. (UK) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.2 Bayer HealthCare Pharmaceuticals (Germany)
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bayer HealthCare Pharmaceuticals (Germany) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bayer HealthCare Pharmaceuticals (Germany) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.3 Bristol-Myers Squibb Company (US)
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bristol-Myers Squibb Company (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bristol-Myers Squibb Company (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.4 Merck & Co., Inc. (US)
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Merck & Co., Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Merck & Co., Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.5 Proteon Therapeutics, Inc. (US)
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Proteon Therapeutics, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Proteon Therapeutics, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.6 Sanofi S.A. (France)
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi S.A. (France) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi S.A. (France) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.7 Symic Bio, Inc. (US)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Symic Bio, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Symic Bio, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.8 TheraVasc Inc. (US)
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 TheraVasc Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 TheraVasc Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.9 AnGes MG, Inc. (Japan)
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 AnGes MG, Inc. (Japan) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 AnGes MG, Inc. (Japan) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.10 Athersys, Inc. (US)
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Athersys, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Athersys, Inc. (US) 2016 Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution Analysis
8.11 Betagenon AB (Sweden)
8.12 miRagen Therapeutics, Inc. (US)
8.13 Multi Gene Vascular Systems Ltd (Israel)
8.14 ViroMed Co. Ltd. (Korea)

9 DEVELOPMENT TREND OF ANALYSIS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET

9.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Sales Price Forecast
9.2 Peripheral Arterial Disease (PAD) Therapeutics Regional Market Trend
  9.2.1 North America 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
  9.2.5 Japan 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
  9.2.6 India 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast
9.3 Peripheral Arterial Disease (PAD) Therapeutics Market Trend (Product Type)
9.4 Peripheral Arterial Disease (PAD) Therapeutics Market Trend (Application)

10 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Peripheral Arterial Disease (PAD) Therapeutics Regional Marketing Type Analysis
10.2 Peripheral Arterial Disease (PAD) Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Peripheral Arterial Disease (PAD) Therapeutics by Region
10.4 Peripheral Arterial Disease (PAD) Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Peripheral Arterial Disease (PAD) Therapeutics
Table Product Specifications of Peripheral Arterial Disease (PAD) Therapeutics
Table Classification of Peripheral Arterial Disease (PAD) Therapeutics
Figure Global Production Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2016
Figure Anti-Platelet Drugs Picture
Table Major Manufacturers of Anti-Platelet Drugs
Figure Dual Antiplatelet Therapy Drugs Picture
Table Major Manufacturers of Dual Antiplatelet Therapy Drugs
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Peripheral Arterial Disease (PAD) Therapeutics
Figure Global Consumption Volume Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Regions
Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Figure India Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2012-2022)
Table Peripheral Arterial Disease (PAD) Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peripheral Arterial Disease (PAD) Therapeutics in 2016
Figure Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics
Figure Industry Chain Structure of Peripheral Arterial Disease (PAD) Therapeutics
Table Capacity and Commercial Production Date of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017
Figure Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Capacity and Growth Rate
Table 2016 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate
Table 2016 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) List (Company Segment)
Table 2012-2017E Global Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Table 2016 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure North America 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure North America 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure China 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure China 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure Europe 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure Europe 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure Japan 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure Japan 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Peripheral Arterial Disease (PAD) Therapeutics 2012-2017E
Figure India 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit)
Figure India 2016 Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share
Table Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type
Table Different Types Peripheral Arterial Disease (PAD) Therapeutics Product Interview Price
Table Global 2012-2017E Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table Different Application Peripheral Arterial Disease (PAD) Therapeutics Product Interview Price
Table AstraZeneca Plc. (UK) Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Bayer HealthCare Pharmaceuticals (Germany) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Bristol-Myers Squibb Company (US) Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Merck & Co., Inc. (US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Proteon Therapeutics, Inc. (US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Sanofi S.A. (France) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Symic Bio, Inc. (US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table TheraVasc Inc. (US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table AnGes MG, Inc. (Japan) Information List
Table Product A Overview
Table Product B Overview
Table 2016 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Athersys, Inc. (US) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Region Distribution
Table Betagenon AB (Sweden) Information List
Table miRagen Therapeutics, Inc. (US) Information List
Table Multi Gene Vascular Systems Ltd (Israel) Information List
Table ViroMed Co. Ltd. (Korea) Information List
Figure Global 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Peripheral Arterial Disease (PAD) Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Peripheral Arterial Disease (PAD) Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Units) of Peripheral Arterial Disease (PAD) Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Peripheral Arterial Disease (PAD) Therapeutics by Region

More Publications

Need Help?

Ask a Question

Market Reports

All Categories